Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PURE-FORMULA

Financiado

Cerrado

Development of a novel control technology for ensuring high quality Powdered Inf...

Development of a novel control technology for ensuring high quality Powdered Infant Formula Powdered Infant Formula (PIF) is a milk-like food intended to supplement or replace the milk of the baby's mother. The quality, nutritional profile and safety of PIF are intrinsic for the health and wellbeing of the babies and inf... ver más

30/09/2015

INNOPHARMA

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

INNOPHARMA LABS LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 7 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-09-30 No tenemos la información de la convocatoria

0% 76% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

7 Participantes

INNOPHARMA

0.00€ | Lider

VTT

N.D. | Participante

INNVACIO I RECERCA INDUSTRIA...

N.D. | Participante

ASSOCIATION OF DAIRY MEAT AN...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

INNOPHARMA LABS LIMITED No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Powdered Infant Formula (PIF) is a milk-like food intended to supplement or replace the milk of the baby's mother. The quality, nutritional profile and safety of PIF are intrinsic for the health and wellbeing of the babies and infants that depend on it for their survival and growth. Since most infant formulae are required to be instant, the preferred drying approach is typically designed to allow for product agglomeration during drying. The agglomeration improves the reconstitution properties. It is important that the degree of agglomeration and its compactness can be controlled. The identified key physical parameters governing the agglomeration process include granule size/shape and the key chemical parameters include moisture content. Properties of individual agglomerates determine bulk powder properties such as powder flowability, bulk density and solubility. These are important product quality characteristics since, for example, the product is measured out on a volume basis (in scoops) whereas nutritional requirements are provided on a mass basis. Thus any changes in particle properties post drying, during conveying and packaging will have implications. For dry blending, the ingredient distribution within granules and between granules has a critical effect on content uniformity, nutrient absorption rates and ultimately infant safety. The development of a hybrid technology that is capable of assessing the physical and nutritional characteristics of PIF in real time would significantly advance process control leading to greater product quality, process validation, and ultimately infant safety. In response the PURE-FORMULA project will develop a novel Process Analytic Technology capable of providing spatial measurements of moisture and ingredient identity from the forming PIF agglomerates. The R&D effort will centre on prototype engineering design, software/algorithm design, user interface design, integration and validation within PIF manufacturing equipment.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores